Evidence map›Paper›PMID 37761874›Full record

SynthesisGenes2023

The Stem Cell Expression Profile of Odontogenic Tumors and Cysts: A Systematic Review and Meta-Analysis.

Eleni-Marina Kalogirou, Georgios Lekakis, Aristodimos Petroulias, Konstantinos Chavdoulas, Vasileios L Zogopoulos, Ioannis Michalopoulos, Konstantinos I Tosios

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Discovery of metabolite biomarkers for odontogenic keratocysts.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eleni-Marina KalogirouFaculty of Health and Rehabilitation Sciences, Metropolitan College, 10672 Athens, Greece.ORCID 0000-0001-7891-4804
Georgios LekakisSchool of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Aristodimos PetrouliasSchool of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Konstantinos ChavdoulasSchool of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vasileios L ZogopoulosCentre of Systems Biology, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.ORCID 0000-0002-4646-5570
Ioannis MichalopoulosCentre of Systems Biology, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.ORCID 0000-0001-8991-8712
Konstantinos I TosiosSchool of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-8834-6078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStem cells have been associated with self-renewing and plasticity and have been investigated in various odontogenic lesions in association with their pathogenesis and biological behavior. We aim to provide a systematic review of stem cell markers' expression in odontogenic tumors and cysts.

methodsThe literature was searched through the MEDLINE/PubMed, EMBASE via OVID, Web of Science, and CINHAL via EBSCO databases for original studies evaluating stem cell markers' expression in different odontogenic tumors/cysts, or an odontogenic disease group and a control group. The studies' risk of bias (RoB) was assessed via a Joanna Briggs Institute Critical Appraisal Tool. Meta-analysis was conducted for markers evaluated in the same pair of odontogenic tumors/cysts in at least two studies.

results29 studies reported the expression of stem cell markers, e.g., SOX2, OCT4, NANOG, CD44, ALDH1, BMI1, and CD105, in various odontogenic lesions, through immunohistochemistry/immunofluorescence, polymerase chain reaction, flow cytometry, microarrays, and RNA-sequencing. Low, moderate, and high RoBs were observed in seven, nine, and thirteen studies, respectively. Meta-analysis revealed a remarkable discriminative ability of SOX2 for ameloblastic carcinomas or odontogenic keratocysts over ameloblastomas.

conclusionStem cells might be linked to the pathogenesis and clinical behavior of odontogenic pathologies and represent a potential target for future individualized therapies.

Indexed as

Neoplastic Stem CellsOdontogenic CystsOdontogenic TumorsStem CellsBiomarkers, TumorHumansBiomarkers, Tumorameloblastic carcinomaameloblastomagene expressionmarkerodontogenic cystodontogenic keratocystodontogenic tumorSOX2stem cellsystematic review

Identifiers

PMID37761874
PMCPMC10531260

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.